Tiotropium Respimat Pharmacokinetic Study in COPD

NCT01222533 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium medium
DRUG: Tiotropium low
DRUG: Tiotropium high
DRUG: Tiotropium 18mcg
DRUG: Tiotropium placebo

Sponsor

Boehringer Ingelheim